Showing 2689 results
-
Event /Novartis announced the company’s financial results for the third quarter of 2022.
-
Event /
-
Event /Novartis announces the company’s fourth quarter and 2022 full year financial results.
-
Event /Novartis announced the company’s financial results for the first quarter of 2023.
-
Event /Novartis announced the company’s financial results for the third quarter of 2023.
-
Event /Latest news and interviews for media and investors
-
Event /Driven by our passion for patients and grounded in our industry-leading pipeline of 45+ different compounds across 70+ development programs, Novartis is rapidly advancing novel cancer treatment…
-
Event /Latest resources and news surrounding Novartis data featured at the 63nd American Society of Hematology Annual Meeting (ASH).
-
Event /We are boldly reimagining cancer and blood disorders.
-
Event /At ASCO this year, we will share new data from our robust portfolio and pipeline of advanced therapeutic platforms in cancer and blood disorders, showcasing the impact of our bold science in research.